Compare Stocks: HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALAB Astera Labs	$311.23 +3.9%	$359.97	$97.89 ▼ $499.48	$51.37B	3.66	4.16 million shs	5.32 million shs
FVRR Fiverr International	$8.93 -2.7%	$10.60	$8.75 ▼ $28.00	$330.03M	1.39	764,614 shs	1.23 million shs
HIMS Hims & Hers Health	$27.79 +2.8%	$31.23	$13.74 ▼ $70.43	$6.26B	2.35	13.99 million shs	12.56 million shs
LLY Eli Lilly and Company	$1,149.28 -0.5%	$1,152.66	$623.78 ▼ $1,249.45	$1.09T	0.51	2.21 million shs	2.88 million shs
NVO Novo Nordisk A/S	$47.20 -8.5%	$46.92	$35.12 ▼ $64.16	$230.44B	0.77	8.26 million shs	26.74 million shs
PAYO Payoneer Global	$7.17 +0.1%	$6.62	$4.08 ▼ $7.66	$2.40B	0.95	3.41 million shs	6.67 million shs
UPWK Upwork	$9.16 -1.0%	$8.77	$7.44 ▼ $22.84	$1.14B	0.99	3.00 million shs	3.28 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALAB Astera Labs	+3.85%	+6.74%	-27.77%	+53.56%	+141.51%
FVRR Fiverr International	-2.88%	-14.69%	-18.54%	-26.89%	-59.61%
HIMS Hims & Hers Health	+2.40%	-1.12%	-26.06%	+1.55%	-57.59%
LLY Eli Lilly and Company	-0.58%	-3.92%	-3.60%	+19.07%	+51.27%
NVO Novo Nordisk A/S	-8.44%	-3.20%	-3.06%	+7.65%	-5.68%
PAYO Payoneer Global	+0.14%	+0.70%	+1.13%	+42.26%	+7.66%
UPWK Upwork	-0.97%	+3.74%	+1.55%	-12.68%	-24.11%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALAB Astera Labs	$311.23 +3.9%	$359.97	$97.89 ▼ $499.48	$51.37B	3.66	4.16 million shs	5.32 million shs
FVRR Fiverr International	$8.93 -2.7%	$10.60	$8.75 ▼ $28.00	$330.03M	1.39	764,614 shs	1.23 million shs
HIMS Hims & Hers Health	$27.79 +2.8%	$31.23	$13.74 ▼ $70.43	$6.26B	2.35	13.99 million shs	12.56 million shs
LLY Eli Lilly and Company	$1,149.28 -0.5%	$1,152.66	$623.78 ▼ $1,249.45	$1.09T	0.51	2.21 million shs	2.88 million shs
NVO Novo Nordisk A/S	$47.20 -8.5%	$46.92	$35.12 ▼ $64.16	$230.44B	0.77	8.26 million shs	26.74 million shs
PAYO Payoneer Global	$7.17 +0.1%	$6.62	$4.08 ▼ $7.66	$2.40B	0.95	3.41 million shs	6.67 million shs
UPWK Upwork	$9.16 -1.0%	$8.77	$7.44 ▼ $22.84	$1.14B	0.99	3.00 million shs	3.28 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALAB Astera Labs	+3.85%	+6.74%	-27.77%	+53.56%	+141.51%
FVRR Fiverr International	-2.88%	-14.69%	-18.54%	-26.89%	-59.61%
HIMS Hims & Hers Health	+2.40%	-1.12%	-26.06%	+1.55%	-57.59%
LLY Eli Lilly and Company	-0.58%	-3.92%	-3.60%	+19.07%	+51.27%
NVO Novo Nordisk A/S	-8.44%	-3.20%	-3.06%	+7.65%	-5.68%
PAYO Payoneer Global	+0.14%	+0.70%	+1.13%	+42.26%	+7.66%
UPWK Upwork	-0.97%	+3.74%	+1.55%	-12.68%	-24.11%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALAB Astera Labs	2.57	Moderate Buy	$284.25	-8.67% Downside
FVRR Fiverr International	1.92	Reduce	$16.25	81.97% Upside
HIMS Hims & Hers Health	2.19	Hold	$31.43	13.12% Upside
LLY Eli Lilly and Company	2.87	Moderate Buy	$1,283.64	11.69% Upside
NVO Novo Nordisk A/S	2.14	Hold	$65.56	38.91% Upside
PAYO Payoneer Global	2.22	Hold	$7.40	3.21% Upside
UPWK Upwork	2.15	Hold	$15.50	69.21% Upside

Current Analyst Ratings Breakdown

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	ALAB Astera Labs	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$230.00 ➝ $275.00
7/30/2026	FVRR Fiverr International	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$13.00 ➝ $10.00
7/30/2026	FVRR Fiverr International	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral	$26.00 ➝ $13.00
7/30/2026	FVRR Fiverr International	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$13.00
7/30/2026	FVRR Fiverr International	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$15.00 ➝ $11.50
7/30/2026	FVRR Fiverr International	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Sector Perform	$16.00 ➝ $9.00
7/30/2026	FVRR Fiverr International	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sector Outperform ➝ Sector Perform	$10.00
7/30/2026	FVRR Fiverr International	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
7/29/2026	UPWK Upwork	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
7/29/2026	ALAB Astera Labs	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/28/2026	FVRR Fiverr International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)

(Data available from 8/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALAB Astera Labs	$852.53M	62.58	$1.25 per share	248.76	$8.07 per share	38.57
FVRR Fiverr International	$430.91M	0.75	$2.45 per share	3.65	$12.16 per share	0.73
HIMS Hims & Hers Health	$2.35B	2.74	$0.86 per share	32.31	$2.38 per share	11.68
LLY Eli Lilly and Company	$72.25B	14.98	$25.02 per share	45.94	$28.07 per share	40.94
NVO Novo Nordisk A/S	$46.80B	4.50	$4.29 per share	11.01	$6.58 per share	7.17
PAYO Payoneer Global	$1.05B	2.28	$0.40 per share	17.99	$2.02 per share	3.55
UPWK Upwork	$787.78M	1.44	$1.03 per share	8.90	$4.83 per share	1.90

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALAB Astera Labs	$219.13M	$1.48	210.29	111.55	3.47	26.72%	18.49%	16.60%	8/4/2026 (Estimated)
FVRR Fiverr International	$20.98M	$0.81	11.02	7.03	N/A	7.18%	16.14%	8.37%	N/A
HIMS Hims & Hers Health	$128.37M	-$0.09	N/A	53.44	76.10	-0.56%	6.10%	1.52%	8/10/2026 (Estimated)
LLY Eli Lilly and Company	$20.64B	$28.15	40.83	25.55	1.43	34.98%	105.77%	23.76%	8/5/2026 (Estimated)
NVO Novo Nordisk A/S	$15.51B	$4.26	11.08	14.43	4.71	37.23%	63.31%	22.19%	8/5/2026 (Estimated)
PAYO Payoneer Global	$73.19M	$0.20	35.85	19.92	0.81	6.76%	11.10%	0.95%	8/6/2026 (Estimated)
UPWK Upwork	$115.43M	$0.81	11.31	N/A	N/A	13.81%	17.92%	8.54%	8/10/2026 (Estimated)

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0490	N/A	N/A	N/A	$698.90 million	N/A
8/10/2026	Q2 2026	UPWK Upwork	$0.35	N/A	N/A	N/A	$189.97 million	N/A
8/6/2026	Q2 2026	PAYO Payoneer Global	$0.0576	N/A	N/A	N/A	$270.98 million	N/A
8/5/2026	Q2 2026	LLY Eli Lilly and Company	$6.06	N/A	N/A	N/A	$20.69 billion	N/A
8/5/2026	Q2 2026	NVO Novo Nordisk A/S	$0.77	N/A	N/A	N/A	$10.88 billion	N/A
8/4/2026	Q2 2026	ALAB Astera Labs	$0.69	N/A	N/A	N/A	$360.59 million	N/A
7/29/2026	Q2 2026	FVRR Fiverr International	$0.52	$0.50	-$0.02	$0.12	$99.46 million	$97.78 million
6/30/2026	Q2 2026	FVRR Fiverr International	N/A	$0.50	N/A	$0.12	N/A	$97.78 million
5/11/2026	Q1 2026	HIMS Hims & Hers Health	$0.04	-$0.40	-$0.44	-$0.40	$616.84 million	$608.10 million
5/7/2026	Q1 2026	PAYO Payoneer Global	$0.04	$0.06	+$0.02	$0.06	$255.12 million	$261.60 million
5/6/2026	Q1 2026	NVO Novo Nordisk A/S	$0.87	$1.04	+$0.17	$1.69	$10.86 billion	$10.85 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALAB Astera Labs	N/A	N/A	N/A	N/A	N/A
FVRR Fiverr International	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LLY Eli Lilly and Company	$6.92	0.60%	+15.18%	24.58%	11 Years
NVO Novo Nordisk A/S	$1.75	3.71%	+21.74%	41.08%	N/A
PAYO Payoneer Global	N/A	N/A	N/A	N/A	N/A
UPWK Upwork	N/A	N/A	N/A	N/A	N/A

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/22/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.63%	8/14/2026	8/14/2026	9/10/2026
5/4/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.69%	5/15/2026	5/15/2026	6/10/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALAB Astera Labs	N/A	11.30	10.82
FVRR Fiverr International	N/A	1.82	1.85
HIMS Hims & Hers Health	2.18	1.69	1.56
LLY Eli Lilly and Company	1.26	1.50	1.10
NVO Novo Nordisk A/S	0.59	0.79	0.56
PAYO Payoneer Global	N/A	1.00	1.00
UPWK Upwork	N/A	1.36	1.36

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALAB Astera Labs	60.47%
FVRR Fiverr International	59.00%
HIMS Hims & Hers Health	63.52%
LLY Eli Lilly and Company	82.53%
NVO Novo Nordisk A/S	11.54%
PAYO Payoneer Global	82.22%
UPWK Upwork	77.71%

Insider Ownership

Company	Insider Ownership
ALAB Astera Labs	10.40%
FVRR Fiverr International	15.90%
HIMS Hims & Hers Health	11.76%
LLY Eli Lilly and Company	0.14%
NVO Novo Nordisk A/S	0.07%
PAYO Payoneer Global	2.06%
UPWK Upwork	4.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALAB Astera Labs	225	171.41 million	153.58 million	Optionable
FVRR Fiverr International	790	35.95 million	30.24 million	Optionable
HIMS Hims & Hers Health	2,442	231.46 million	204.24 million	Optionable
LLY Eli Lilly and Company	50,000	941.74 million	940.42 million	Optionable
NVO Novo Nordisk A/S	69,505	4.47 billion	4.46 billion	Optionable
PAYO Payoneer Global	2,540	334.78 million	327.88 million	Optionable
UPWK Upwork	850	123.52 million	117.47 million	Optionable

HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Headlines

Recent News About These Companies

Renaissance Technologies LLC Sells 118,722 Shares of Upwork Inc. $UPWK

July 30 at 5:04 AM | marketbeat.com

Upwork Inc. (NASDAQ:UPWK) Given Average Recommendation of "Hold" by Analysts

July 30 at 2:44 AM | americanbankingnews.com

Upwork Inc. (NASDAQ:UPWK) Receives Consensus Rating of "Hold" from Brokerages

July 30 at 2:43 AM | marketbeat.com

Why Upwork (UPWK) shares are sliding today

July 30 at 1:00 AM | msn.com

Rice Hall James & Associates LLC Takes Position in Upwork Inc. $UPWK

July 26, 2026 | marketbeat.com

RBC Capital Remains a Hold on Upwork (UPWK)

July 25, 2026 | theglobeandmail.com

Principal Financial Group Inc. Grows Position in Upwork Inc. $UPWK

July 25, 2026 | marketbeat.com

Sanctuary Advisors LLC Has $1.63 Million Stock Holdings in Upwork Inc. $UPWK

July 23, 2026 | marketbeat.com

Upwork to Report Second Quarter Financial Results on August 10, 2026

July 21, 2026 | globenewswire.com

Upwork Remains Cheap For A Reason

July 20, 2026 | seekingalpha.com

Analysts Offer Insights on Communication Services Companies: Echostar (ECHO) and Upwork (UPWK)

July 18, 2026 | theglobeandmail.com

Upwork (NASDAQ:UPWK) Trading Down 8.3% - What's Next?

July 17, 2026 | marketbeat.com

Upwork CEO Assumes Interim Finance Duties During Leave

July 17, 2026 | tipranks.com

Upwork vs. Wix.com: Which Tech Stock Is a Better Buy in 2026?

July 15, 2026 | fool.com

Upwork Releases 2026 Future Workforce Index, Finding AI Is Reshaping Freelance Work and Earnings

July 14, 2026 | quiverquant.comQ

Upwork's Future Workforce Index 2026: How AI is Redefining the Value of Work as Skilled Freelancing Accelerates

July 14, 2026 | globenewswire.com

SG Americas Securities LLC Lowers Stock Holdings in Upwork Inc. $UPWK

July 10, 2026 | marketbeat.com

Upwork: Signs Of Disruption Are Now Clearly Here (Downgrade)

July 3, 2026 | seekingalpha.com

Gig economy stocks Q1 results: Benchmarking Fiverr (NYSE:FVRR)

June 26, 2026 | msn.com

Reflecting on gig economy stocks’ Q1 earnings: Upwork (NASDAQ:UPWK)

June 26, 2026 | msn.com

Upwork and Yelp shares are soaring, what you need to know

June 24, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Company Descriptions

Astera Labs NASDAQ:ALAB

$311.23 +11.54 (+3.85%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$305.50 -5.73 (-1.84%)

As of 07/31/2026 07:59 PM Eastern

Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale. The company was incorporated in 2017 and is based in Santa Clara, California.

Fiverr International NYSE:FVRR

$8.93 -0.25 (-2.72%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$8.91 -0.02 (-0.24%)

As of 07/31/2026 07:57 PM Eastern

Fiverr International Ltd. operates an online marketplace worldwide. Its platform enables sellers to sell their services and buyers to buy them. The company's platform includes various categories in ten verticals, including graphic and design, digital marketing, writing and translation, video and animation, music and audio, programming and tech, business, data, lifestyle, and photography. It also offers value-added products, including subscription-based content marketing, back-office, learning and development offerings, creative talent, and freelancer management platforms. In addition, the company provides a suite of professional solutions that enable businesses to engage with freelancers; Fiverr Pro, a marketplace; Fiverr Certified, a storefront to access certified experts for partner vendors; Fiverr Enterprise, a gateway to source and manage on-demand and long-term freelancers. Further, it offers various value-added products, including Promoted Gigs which allows sellers to advertise their services on the platform; and Seller Plus, a subscription program that equips sellers with advanced tools. The company's buyers include businesses of various sizes, as well as sellers comprise a group of freelancers and agencies. Fiverr International Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

Hims & Hers Health NYSE:HIMS

$27.79 +0.75 (+2.76%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$27.55 -0.24 (-0.85%)

As of 07/31/2026 07:58 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Eli Lilly and Company NYSE:LLY

$1,149.28 -5.69 (-0.49%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$1,148.80 -0.48 (-0.04%)

As of 07/31/2026 08:00 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Novo Nordisk A/S NYSE:NVO

$47.20 -4.41 (-8.55%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$46.96 -0.24 (-0.51%)

As of 07/31/2026 08:00 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Payoneer Global NASDAQ:PAYO

$7.17 +0.01 (+0.14%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$7.17 0.00 (0.00%)

As of 07/31/2026 07:34 PM Eastern

Payoneer Global Inc. operates as a financial technology company. It operates a payment infrastructure platform that provides customers with a one-stop, global, multi-currency account to serve their accounts receivable and accounts payable needs. The company delivers a suite of services that includes cross-border payments, physical and virtual MasterCard cards, working capital, risk management, and other services. It also offers various payment options with minimal integration required, full back-office functions, and customer support offered. The company's platform delivers bank-grade security, stability, and redundancy. It serves customers, such as small and medium-sized businesses in approximately 190 countries and territories worldwide. Payoneer Global Inc. was founded in 2005 and is headquartered in New York, New York.

Upwork NASDAQ:UPWK

$9.16 -0.09 (-0.97%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$9.16 0.00 (-0.04%)

As of 07/31/2026 07:59 PM Eastern

Upwork Inc., together with its subsidiaries, operates a work marketplace that connects businesses with various independent professionals and agencies in the United States, India, the Philippines, and internationally. The company's work marketplace provides access to talent with various skills across a range of categories, including administrative support, sales and marketing, design and creative, and customer service, as well as web, mobile, and software development. Its work marketplace also enables clients to streamline workflows, such as talent sourcing, outreach, and contracting. The company's work marketplace offers access to various functionalities for remote engagements with talent, including communication and collaboration, ability to receive talent invoices through their work marketplace, and payment protection. Its marketplace offerings include Upwork Payroll and Upwork Enterprise, as well as managed and escrow services. The company was formerly known as Elance-oDesk, Inc. and changed its name to Upwork Inc. in May 2015. Upwork Inc. was incorporated in 2013 and is headquartered in San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Earnings

Compare Dividends

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Company Descriptions

Astera Labs NASDAQ:ALAB

Fiverr International NYSE:FVRR

Hims & Hers Health NYSE:HIMS

Eli Lilly and Company NYSE:LLY

Novo Nordisk A/S NYSE:NVO

Payoneer Global NASDAQ:PAYO

Upwork NASDAQ:UPWK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools